PolyPid Ltd. (NASDAQ: PYPD) announced it will present data from its SHIELD II Phase 3 trial at the Surgical Infection ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE